首页> 外文期刊>Evidence-based ophthalmology >REDUCED INCIDENCE OF INTRAOPERATIVE COMPLICATIONS IN A MULTICENTER CONTROLLED CLINICAL TRIAL OF TRIAMCINOLONE IN VITRECTOMY
【24h】

REDUCED INCIDENCE OF INTRAOPERATIVE COMPLICATIONS IN A MULTICENTER CONTROLLED CLINICAL TRIAL OF TRIAMCINOLONE IN VITRECTOMY

机译:减少了曲安奈德在多中心控制的临床试验中在玻璃体视网膜手术中并发症的发生率

获取原文
获取原文并翻译 | 示例
           

摘要

Research Objective To evaluate the benefits and potential complications of using triamcinolone acetonide (TA) in pars plana vitrectomy (PPV). Study Design Multicenter, prospective, controlled clinical trial. Location Eight hospitals in Japan. Funding Source The Ministry of Education, Science and Culture, Tokyo, Japan. Relevant Methodology Seven hundred seventy-four patients from 8 hospitals in Japan were enrolled in this study. Three hundred ninety-one patients underwent TA-assisted PPV and 383 control patients underwent conventional PPV. Outcome Measures Incidence of intraoperative complications, including retinal breaks and early postoperative complications, intraocular pressure (IOP), and adverse events occurring within 3 months of the operation.
机译:研究目的评估曲安奈德(TA)在平面玻璃体切除术(PPV)中的益处和潜在的并发症。研究设计多中心,前瞻性,对照临床试验。地点日本有八家医院。资金来源教育,科学和文化部,日本东京。相关方法本研究招募了来自日本8家医院的774名患者。 391例患者接受了TA辅助PPV,383例对照患者接受了常规PPV。结果测量术中并发症的发生率,包括视网膜裂孔和术后早期并发症,眼压(IOP)以及术后3个月内发生的不良事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号